BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12825049)

  • 1. Octreotide in the medical management of chyle fistula.
    Nyquist GG; Hagr A; Sobol SE; Hier MP; Black MJ
    Otolaryngol Head Neck Surg; 2003 Jun; 128(6):910-1. PubMed ID: 12825049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chyle fistula. Medical management with octreotide].
    Bejarano Glez-Serna D; Utrera-Glez A; Cordoncillo-Prieto JM; de la Portilla de Juan F; Rada-Morgades R; Carranza-Albarran G
    Cir Esp; 2006 Apr; 79(4):250-1. PubMed ID: 16753107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Octreotide for the Management of Chyle Fistula Following Neck Dissection.
    Swanson MS; Hudson RL; Bhandari N; Sinha UK; Maceri DR; Kokot N
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):723-7. PubMed ID: 26135979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chyle Fistula After Neck Dissection: An 8-Year, Single-Center, Prospective Study of Incidence, Clinical Features, and Treatment.
    Ahn D; Sohn JH; Jeong JY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1000-6. PubMed ID: 26286200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide versus oral dietary modification for the treatment of chylous fistula following neck dissection: A systematic review and meta-analysis.
    Molena E; King E; Davies-Husband C
    Clin Otolaryngol; 2021 May; 46(3):474-484. PubMed ID: 33342047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study on the role of octreotide in management of chyle fistula neck.
    Jain A; Singh SN; Singhal P; Sharma MP; Grover M
    Laryngoscope; 2015 Jul; 125(7):1624-7. PubMed ID: 25639346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin in medical management of chyle fistula after neck dissection for papillary thyroid carcinoma.
    Coşkun A; Yildirim M
    Am J Otolaryngol; 2010; 31(5):395-6. PubMed ID: 20015785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of octreotide in the treatment of chyle fistulas associated with pancreatic disease].
    Zárate Moreno FA; Oms Bernad LM; Mato Ruiz R; Balaguer del Ojo C; Sala Pedrós J; Campillo Alonso F
    Cir Esp; 2013 Apr; 91(4):237-42. PubMed ID: 23228417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management of postoperative chylous fistula with octreotide and peripheral total parenteral nutrition.
    Chan JY; Wong EW; Ng SK; van Hasselt CA; Vlantis AC
    Ear Nose Throat J; 2017 Jul; 96(7):264-267. PubMed ID: 28719710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doxycycline and octreotide in medical management of cervical lymphorrhagia: a failed case].
    Martínez-Santana V; Sánchez-Sánchez T; López-González AM
    Farm Hosp; 2013; 37(2):168-9. PubMed ID: 23789763
    [No Abstract]   [Full Text] [Related]  

  • 11. Chyle fistula as complication of thyroid surgery in malignant pathology.
    Ríos A; Rodríguez JM; Torregrosa NM; Hernández AM; Parrilla P
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Apr; 66(4):247-253. PubMed ID: 30309811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of biliobronchial fistula with octreotide: a case report.
    Petrolati A; Pacella CM; Nasoni S; Rossi Z; Altavilla N; Cipolla R; Fenderico P; Forlini G; Stasi R
    Am J Gastroenterol; 2009 Oct; 104(10):2638-9. PubMed ID: 19806104
    [No Abstract]   [Full Text] [Related]  

  • 13. Octreotide for treatment of postoperative chylothorax.
    Cheung Y; Leung MP; Yip M
    J Pediatr; 2001 Jul; 139(1):157-9. PubMed ID: 11445812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hypersecretory ileostomy, gastrostomy and fistula of the small intestine with the somatostatin analog octreotide].
    Lindsetmo RO; Revhaug A
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2829-30. PubMed ID: 7998027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide as a therapeutic option for management of chylothorax.
    Al-Zubairy SA; Al-Jazairi AS
    Ann Pharmacother; 2003 May; 37(5):679-82. PubMed ID: 12708946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatico-pleural fistula: successful treatment with octreotide.
    Poddar U; Kochhar R; Singh A; Nagi B; Singh K
    Indian J Gastroenterol; 1995 Oct; 14(4):145-6. PubMed ID: 8868358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.
    Chen RJ; Fang JF; Chen MF
    Am J Gastroenterol; 1992 Sep; 87(9):1212-5. PubMed ID: 1519586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of octreotide acetate in the treatment of a pancreatic-pleural fistula. Apropos of a case].
    Courtin JP; Di Francia M; Poubeau P; Arvin-Berod C
    Rev Pneumol Clin; 1994; 50(2):74-6. PubMed ID: 7839054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide therapy for pancreaticopleural fistula.
    Chan KL; Lau WY; Sung JY
    J Gastroenterol Hepatol; 1994; 9(5):530-2. PubMed ID: 7827309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.